Holen Sie sich die Stockscreener-App
1.47
2.08%
0.03
Vorhandelsmarkt:
1.52
0.05
+3.40%
Schlusskurs vom Vortag:
$1.44
Offen:
$1.45
24-Stunden-Volumen:
16.69M
Relative Volume:
1.41
Marktkapitalisierung:
$938.38M
Einnahmen:
$183.40M
Nettoeinkommen (Verlust:
$-79.99M
KGV:
-12.23
EPS:
-0.1202
Netto-Cashflow:
$-132.69M
1W Leistung:
-14.53%
1M Leistung:
+0.00%
6M Leistung:
+6.52%
1J Leistung:
-11.45%
1-Tages-Spanne:
$1.40
$1.51
1-Wochen-Bereich:
$1.40
$1.75
52-Wochen-Spanne:
$1.04
$2.01
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.47 | 919.23M | 183.40M | -79.99M | -132.69M | -0.1202 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Sell |
| 2025-05-08 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Soleus files 5.2% stake in Geron (GERN) via master fund - Stock Titan
Is Geron (GERN) Using Its New ATM Program To Prioritize Flexibility Over Shareholder Dilution? - Yahoo Finance
Geron at TD Cowen: Strategic Growth and Market Expansion - Investing.com
Geron (NASDAQ: GERN) launches $150M ATM sales agreement with TD Cowen - Stock Titan
Geron 10-K: Revenue $183.9M, EPS (0.13) - TradingView
HC Wainwright Issues Optimistic Outlook for Geron Earnings - MarketBeat
Geron (GERN) 2025 Revenue Surges to $183.6M Driven by RYTELO Commercial Success - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Q4 2025 Earnings Call Transcript - Insider Monkey
Geron (GERN) Pops on FDA Nod: Is This Small-Cap Biotech Now Underpriced? - AD HOC NEWS
Geron shares drop after Q4 results miss estimates despite Rytelo growth - MSN
Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments - Investing.com Canada
Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Geron (GERN) Projects Strong Revenue and Manages Expenses for 20 - GuruFocus
Why Geron (GERN) Is Up 8.3% After Narrowing Losses And Boosting 2026 RYTELO Outlook - simplywall.st
Geron Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Geron (NASDAQ:GERN) Releases Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Why Did GERN Stock Tumble 10% Pre-Market Today? - Stocktwits
Geron Q4 Earnings Call Highlights - MarketBeat
Geron Corporation (GERN) Shares Plummet After Missing Q4 2025 Ex - GuruFocus
Earnings call transcript: Geron Q4 2025 results miss forecasts, stock plunges - Investing.com
Geron (GERN) Targets RYTELO Growth with Strategic Actions in 202 - GuruFocus
Geron: Overview of Fourth Quarter Financial Results - Bitget
Geron earnings missed by $0.02, revenue fell short of estimates - Investing.com
GERON ($GERN) Releases Q4 2025 Earnings - Quiver Quantitative
Geron: Q4 Earnings Snapshot - Barchart.com
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - TradingView
RYTELO drives Geron (GERN) 2025 revenue surge and 2026 guidance - Stock Titan
Geron Corporation Reports $184 Million in RYTELO® Revenue for 2025 and Provides 2026 Financial Guidance - Quiver Quantitative
Earnings Summary: Geron Q4 - Benzinga
Cancer drug RYTELO brings in $184M as Geron cuts a third of staff - Stock Titan
Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Assessing Geron (GERN) Valuation After Recent Short Term Share Price Momentum - Yahoo Finance
Geron Corp. Stock Hits Day Low of $1.72 Amid Price Pressure - Markets Mojo
Geron (GERN) Set to Announce Q4 Earnings - GuruFocus
Geron (NASDAQ:GERN) Stock Price Up 8.8%Still a Buy? - MarketBeat
Geron Corporation Q4 Financial Announcement Sparks Investor Curiosity - StocksToTrade
Is Geron (GERN) Pricing Look Attractive After Recent Share Price Rebound? - Yahoo Finance
Geron earnings up next: Can RYTELO sustain revenue momentum? By Investing.com - Investing.com South Africa
Geron earnings up next: Can RYTELO sustain revenue momentum? - Investing.com
Geron (GERN) Sets 2026 Financial Goals, TD Cowen Cuts PT - Insider Monkey
Geron Plans to Present at Upcoming Investor Conferences - The Manila Times
Geron Corporation Management to Present at Upcoming Investor Conferences in March 2026 - Quiver Quantitative
Does Geron Corporation offer margin of safetyQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - mfd.ru
Geron (NASDAQ:GERN) Trading Down 6%Here's Why - MarketBeat
Geron Corporation (GERN) Stock Analysis: An Insight into the Biotech Player’s 77% Potential Upside - DirectorsTalk Interviews
Top 2 Industrials Stocks That Are Ticking Portfolio Bombs - Benzinga
Gains Report: Will Geron Corporation benefit from geopolitical trendsGold Moves & Fast Moving Trade Plans - baoquankhu1.vn
Geron (GERN) CFO granted 1.66M options and sells shares for taxes - Stock Titan
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
6.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):